Clinical trial Recruiting at 1 site Interventional Ages 7 to 18 Men only

VR-based upper limb training for kids and teens with Duchenne muscular dystrophy

Official title: The Effect of Virtual Reality Applications on Upper Extremity Functions in Patients With Duchenne Muscular Dystrophy

Run by Istanbul University · NCT07039799 · Data updated 2026-11-12

This study tests whether immersive virtual reality plus standard physical therapy improves arm and hand function in young people with Duchenne muscular dystrophy compared with standard therapy alone.

Quick facts

Study typeInterventional
Ages7 Years to 18 Years
SexMen only
Enrollment36 (estimated)
SponsorIstanbul University
Academic / other
Locations1 site (Istanbul, Fatih)
StatusRecruiting
StartedAugust 15, 2025
Main results expectedFebruary 15, 2027
Study endsAugust 15, 2027
Registry record updatedMay 19, 2026
Trial IDNCT07039799 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Children and adolescents with DMD, aged 7 years or older, who can follow movement instructions and have a Brooke UE Functional Rating Scale score of 4 or less.

Probably not a fit

Individuals unable to participate in VR training due to severe contractures, visual impairments, or other barriers may not benefit from this intervention.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This randomized trial will enroll 36 participants with Duchenne muscular dystrophy to compare two approaches for upper-extremity rehab. One group receives conventional physiotherapy including upper-extremity exercises plus immersive VR-based training, while the control group receives the same physiotherapy without the VR component. Interventions occur twice weekly for 8 weeks, with assessments before, after, and at a follow‑up using validated measures. The VR program uses Meta Quest 3 headsets with hand-tracking to target shoulder, elbow, wrist, and hand movements. The study also includes formative usability evaluation of the VR rehabilitation platform to inform future use in this population.

Why it matters

Potential benefit: If successful, participants may experience improved upper-extremity function and greater engagement in rehabilitation activities.

How similar studies have gone: Prior work suggests VR-assisted rehab can improve motor function and motivation in pediatric neurorehabilitation, but evidence specific to DMD and upper-limb outcomes is limited.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Clinical diagnosis of Duchenne Muscular Dystrophy (DMD)
* Age ≥ 7 years
* Ambulatory or non-ambulatory status (both are eligible)
* Ability to follow movement instructions
* Brooke Upper Extremity Functional Rating Scale (BUEFS) level ≤ 4 (i.e., able to bring hand to mouth)

Exclusion Criteria:

* Presence of any neurological diagnosis other than DMD
* Cognitive, behavioral, or communication impairments that limit participation
* Systemic illness or condition interfering with participation
* Severe visual impairments incompatible with VR headset use
* Presence of severe contractures or deformities that prevent execution of VR-based exercises

Where it's running

  • İstanbul Üniversitesi Cerrahpaşa Tıp Fakültesi
    Istanbul, Fatih, Turkey (Türkiye)
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.